In a significant victory, Frier Levitt assisted a New York based pharmacy client in successfully challenging audit findings by a major Pharmacy Benefit Manager (“PBM”) resulting in the retrieval of over $1.1 million. In the Initial Findings,... Read More
Frier Levitt Life Sciences attorneys, Dae Y. Lee, Pharm.D., Esq., CPBS and Jonathan Levitt, Esq. co-authored an article titled: “The Consolidated Appropriations Act and PBM Transparency” in Pharmaceutical Commerce on May 12, 2023. In this... Read More
In recent years, the government has intensified its scrutiny of healthcare providers, with a particular focus on pharmacies. Independent pharmacies and pharmacy owners must be aware of a growing trend in government investigations regarding the... Read More
In a significant development that could impact the future of prescription drug costs, the U.S. Federal Trade Commission (“FTC”) announced an expansion of its investigation into the country’s leading Pharmacy Benefit Managers (“PBMs”). ... Read More
Pharmacies face serious PBM risks when issues that arise in audits are not properly addressed from recoupments and network terminations, to governmental investigations. Preparation and preventative measures are key to ensuring a positive audit... Read More
Frier Levitt Life Sciences attorneys, Dae Y. Lee, Pharm.D., Esq., CPBS and Jonathan Levitt, Esq. co-authored an article titled: “The Consolidated Appropriations Act and PBM Transparency” in Pharmaceutical Executive on May 12, 2023. In this... Read More
As discussed in our recent article, the Consolidated Appropriations Act of 2021 (the “CAA”) levels the playing field between pharmacy benefit managers (“PBMs”) and their employee healthcare benefit plan clients (“Plans”) by creating new... Read More
In an alarming trend, a manufacturer of diabetic test strip has taken actions against pharmacies alleging that they purchased the manufacturer’s test strips (the “Test Strips”) from unauthorized distributors or wholesalers. The manufacturer... Read More
Frier Levitt recently helped a New York based pharmacy overturn a network enrollment denial by a major Pharmacy Benefit Manager (“PBM”). The PBM rejected the pharmacy’s enrollment application due to allegations of “common association or... Read More
Frier Levitt was recently successful in reversing a plan-initiated PBM network termination for NJ pharmacies that are under common ownership. Back in 2019, the PBM conducted an audit over the pharmacies on behalf of its plan client and alleged... Read More